Insider Transactions Reported by 21 Insiders of Viridian Therapeutics, Inc.\DE

Symbol
VRDN on Nasdaq
Location
Waltham, MA

Insiders trading volume in the past year

Viridian Therapeutics, Inc.\DE executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Fairmount Funds Management LLC Director, 10%+ Owner $86,118,076 +$9,999,990 +13% 23 Oct 2025
Frazier Life Sciences Public Fund, L.P. 10%+ Owner $31,609,200 23 Sep 2021
Jonathan Violin Chief Executive Officer, Director $10,099,005 02 Feb 2023
Scott Dunseth Myers Chief Executive Officer, Director $5,449,500 12 Apr 2023
Stephen F. Mahoney President and CEO, Director $2,721,419 03 Mar 2026
Thomas W. Beetham Chief Operating Officer $1,282,690 03 Mar 2026
Seth Harmon Chief Financial Officer $822,813 03 Mar 2026
Lara Meisner Chief Legal Officer $629,391 15 Jun 2023
Jennifer Tousignant Chief Legal Officer $589,124 -$70,796 -11% 03 Mar 2026
Thomas Ciulla Chief Medical Officer $16,002 05 Feb 2024
Carrie Melvin Coo 08 Feb 2023
Peter Evan Harwin Director 26 Jun 2024
Jeffrey Robert Ajer Director 01 Jul 2025
Radhika Tripuraneni Chief Medical Officer 02 Mar 2026
Sarah Gheuens Director 01 Jul 2025
Tomas Kiselak Director 01 Jul 2025
Christopher W. Cain Director 01 Jul 2025
Kristian Humer CFO and CBO 08 Feb 2023
Arlene Morris Director 01 Jul 2025
Jennifer K. Moses Director 01 Jul 2025
Barrett Katz Chief Medical Officer 08 Feb 2023

Recent Insider Transactions by Companies or Individuals for Viridian Therapeutics, Inc.\DE

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Seth Harmon VRDN Common Stock Tax liability -20.6% -2,031 7,850 03 Mar 2026 Direct
Thomas W. Beetham VRDN Common Stock Tax liability -18.6% -3,048 13,361 03 Mar 2026 Direct
Jennifer Tousignant VRDN Common Stock Tax liability -32.4% -1,675 3,494 03 Mar 2026 Direct
Stephen F. Mahoney VRDN Common Stock Tax liability -18.2% -7,408 33,349 03 Mar 2026 Direct
Jennifer Tousignant VRDN Common Stock Tax liability -33.4% -1,724 3,445 03 Mar 2026 Direct
Jennifer Tousignant VRDN Common Stock Options Exercise 5,169 5,169 03 Mar 2026 Direct
Jennifer Tousignant VRDN Restricted Stock Units Options Exercise -25% -5,169 15,510 03 Mar 2026 Direct
Seth Harmon VRDN Common Stock Tax liability -21.2% -2,091 7,790 03 Mar 2026 Direct
Seth Harmon VRDN Common Stock Options Exercise 173.4% 6,267 9,881 03 Mar 2026 Direct
Seth Harmon VRDN Restricted Stock Units Options Exercise -25% -6,267 18,801 03 Mar 2026 Direct
Thomas W. Beetham VRDN Common Stock Tax liability -19.1% -3,138 13,271 03 Mar 2026 Direct
Thomas W. Beetham VRDN Common Stock Options Exercise 134.4% 9,409 16,409 03 Mar 2026 Direct
Thomas W. Beetham VRDN Restricted Stock Units Options Exercise -25% -9,409 28,227 03 Mar 2026 Direct
Stephen F. Mahoney VRDN Common Stock Tax liability -18.7% -7,627 33,130 03 Mar 2026 Direct
Stephen F. Mahoney VRDN Common Stock Options Exercise 82% 18,357 40,757 03 Mar 2026 Direct
Stephen F. Mahoney VRDN Restricted Stock Units Options Exercise -25% -18,357 55,071 03 Mar 2026 Direct
Jennifer Tousignant VRDN Restricted Stock Units Award 23,850 23,850 02 Mar 2026 Direct
Jennifer Tousignant VRDN Stock Option (Right to Buy) Award 119,300 119,300 02 Mar 2026 Direct
Seth Harmon VRDN Restricted Stock Units Award 20,550 20,550 02 Mar 2026 Direct
Seth Harmon VRDN Stock Option (Right to Buy) Award 102,850 102,850 02 Mar 2026 Direct
Thomas W. Beetham VRDN Restricted Stock Units Award 35,300 35,300 02 Mar 2026 Direct
Thomas W. Beetham VRDN Stock Option (Right to Buy) Award 176,550 176,550 02 Mar 2026 Direct
Stephen F. Mahoney VRDN Restricted Stock Units Award 111,900 111,900 02 Mar 2026 Direct
Stephen F. Mahoney VRDN Stock Option (Right to Buy) Award 559,600 559,600 02 Mar 2026 Direct
Radhika Tripuraneni VRDN Restricted Stock Units Award 19,150 19,150 02 Mar 2026 Direct
Radhika Tripuraneni VRDN Stock Option (Right to Buy) Award 95,800 95,800 02 Mar 2026 Direct
Jennifer Tousignant VRDN Common Stock Sale -100% $70,796 $31.16 -2,272 0 31 Dec 2025 Direct
Fairmount Funds Management LLC VRDN Common Stock Purchase 13.1% $9,999,990 $22.00 454,545 3,914,458 23 Oct 2025 Fairmount Healthcare Fund II LP
Christopher W. Cain VRDN Stock Option (Right to Buy) Award 21,000 21,000 01 Jul 2025 See Footnote
Tomas Kiselak VRDN Stock Option (Right to Buy) Award 21,000 21,000 01 Jul 2025 See Footnote
Arlene Morris VRDN Stock Option (Right to Buy) Award 21,000 21,000 01 Jul 2025 Direct
Jeffrey Robert Ajer VRDN Stock Option (Right to Buy) Award 21,000 21,000 01 Jul 2025 Direct
Sarah Gheuens VRDN Stock Option (Right to Buy) Award 21,000 21,000 01 Jul 2025 Direct
Jennifer K. Moses VRDN Stock Option (Right to Buy) Award 21,000 21,000 01 Jul 2025 Direct
Fairmount Funds Management LLC VRDN Common Stock Options Exercise 0.36% 12,500 3,459,913 10 Jun 2025 Fairmount Healthcare Fund II LP
Fairmount Funds Management LLC VRDN Stock Option (Right to Buy) Options Exercise -100% -12,500 0 10 Jun 2025 By: Peter Harwin
Fairmount Funds Management LLC VRDN Common Stock Options Exercise 0.05% 1,600 3,447,413 09 Jun 2025 Fairmount Healthcare Fund II LP
Fairmount Funds Management LLC VRDN Stock Option (Right to Buy) Options Exercise -100% -1,600 0 09 Jun 2025 By: Peter Harwin
Jeffrey Robert Ajer VRDN Stock Option (Right to Buy) Award 42,000 42,000 07 Apr 2025 Direct
Radhika Tripuraneni VRDN Stock Option (Right to Buy) Award 310,700 310,700 10 Mar 2025 Direct
Christopher W. Cain VRDN Stock Option (Right to Buy) Award 42,000 42,000 10 Mar 2025 See Footnote
Stephen F. Mahoney VRDN Restricted Stock Units Award 73,428 73,428 03 Mar 2025 Direct
Stephen F. Mahoney VRDN Stock Option (Right to Buy) Award 440,565 440,565 03 Mar 2025 Direct
Thomas W. Beetham VRDN Restricted Stock Units Award 37,636 37,636 03 Mar 2025 Direct
Thomas W. Beetham VRDN Stock Option (Right to Buy) Award 225,814 225,814 03 Mar 2025 Direct
Thomas W. Beetham VRDN Common Stock Purchase 500% $117,050 $23.41 5,000 6,000 27 Sep 2024 Direct
Stephen F. Mahoney VRDN Common Stock Purchase $499,262 $23.33 21,400 21,400 27 Sep 2024 Direct
Fairmount Funds Management LLC VRDN Common Stock Purchase 86.7% $30,000,000 $18.75 1,600,000 3,445,813 13 Sep 2024 Fairmount Healthcare Fund II LP
Sarah Gheuens VRDN Stock Option (Right to Buy) Award 21,000 21,000 26 Jun 2024 Direct
Arlene Morris VRDN Stock Option (Right to Buy) Award 21,000 21,000 26 Jun 2024 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.